Major Milestone: Inura Medical Closes Pre-series A Financing Round – Inura Medical AG
Summary
Our mission is to improve womens health through the development of an urethral ovulum for the treatment of patients suffering from urinary bladder diseases. Thus, our first pharmaceutical product is addressing an unmet medical need in overactive bladder (OAB).The investment proceeds from this round will be used to continue business development and finalize the pre-clinical work. The pre-clinical trials in dogs started this month, and the First-In-Human study preparations are ongoing.This financing round was a major milestone for our team. Im very proud to participate in the further development of the company and thereby contribute to improving patients lives, remarked Vanja Ivancevic, CEO of Inura Medical.Inuras novel product has the potential to revolutionize the quality of life of patients suffering from OAB and dramatically change the way they cope with their health disorder and gain back control of their lives.Inura Medical AG (Inura) is a Swiss start-up company with a clear vision to make a difference in womens health. Inuras product is an innovative, first-of-a-kind urethral ovulum that utilizes a novel route of drug administration to treat diseases of the bladder and lower urinary tract.